CPT1 carnitine palmitoyltransferase 1 CREB cAMP response element binding protein CTGF connective tissue growth factor cTnC Troponin C cTnI Troponin I cTnT Troponin T CVD cardiovascular diseases CYR61 Cysteine-Rich angiogenic inducer 61 ECG electrocardiogram ECM extracellular matrix eIF4E Eukaryotic translation initiation factor 4E EPI epinephrine ErbB2 erythroblastic leukemia viral oncogene homolog 2 ErbB4 erythroblastic leukemia viral oncogene homolog 4 FAO fatty acid oxidation FasL Fas Ligand FBXW7 F-box and WD repeat domain-containing protein 7 FFA free fatty acids FOXO forkhead box O G6P Glucose-6-Phosphate Gal-3 Galectin-3 GATA4 GATA binding protein 4 Gck glucokinase gene GH growth hormone GLUT4 glucose transporter type 4 GS glycogen synthase GSK-3 glycogen synthase kinase-3 beta H3K27ac acetylation of histone H3 at lysine 27 H3K9ac acetylation of histone H3 at lysine 9 HATs histone acetyltransferase HDACs histone deacetylases HIIT High-intensity Interval Training Hmbox1 homeobox containing 1 IGF-1 insulin-like growth factor 1 IGF-1R insulin-like growth factor 1 receptor IL-2 Interleukin-2 IRS insulin receptor substrate LATS1/2 large tumor suppressor kinases 1 and 2 LEF lymphoid enhancer factor LVEDV left ventricular end-diastolic volume LVEF left ventricular ejection fraction LVFP left ventricular filling pressure LVM left ventricular mass LVMI left ventricular mass index LVST interventricular septal thickness LVWT left ventricular wall thickness m6A N6-methyladenosine MAPK mitogen activated protein kinase MCAD medium-chain acyl-coA dehydrogenase MEF2 myocyte enhancer factor 2 METTL14 Methyltransferase like 14 MFN2 Mitofusin 2 MH myocardial hypertrophy miR-195-5p MicroRNA-195-5p MMP-9 matrix metalloproteinase-9 MST1/2 mammalian sterile 20-like kinase 1/2 mTORC1 mammalian target of rapamycin protein complex 1 mTORC2 mammalian target of rapamycin protein complex 2 NFAT nuclear factor of activated T-cells NLS nuclear localization signal NRG1 Neuregulin 1 p27 cyclin-dependent kinase inhibitor 1B PCH physiological cardiac hypertrophy PDK1 pyruvate dehydrogenase kinase 1 PGC-1 peroxisome proliferator-activated receptor gamma coactivator 1-Alpha PHLPP2 Pleckstrin homology domain leucine - rich repeat protein phosphatase 2 PI3K Phosphatidylinositol 3-Kinase PIIINP procollagen type III N-Terminal propeptide PINP procollagen type I N-Terminal propeptide PIP2 phosphatidylinositol 4,5-bisphosphate PIP3 phosphatidylinositol (3,4,5)-trisphosphate PKA protein kinase A PMH pathological myocardial hypertrophy PP5 protein phosphatase 5 PPAR peroxisome proliferator-activated receptor alpha Rheb GTP Ras homolog enriched in brain guanosine triphosphate ROCK rho-associated coiled-coil containing protein kinase RVEF right ventricular ejection fraction RyR ryanodine receptor S6K1 ribosomal protein S6 kinase 1 SAV1 Salvador homolog 1 SI strain imaging SV stroke volume TAZ transcriptional coactivator with PDZ-binding motif TCF transcription factor 4 TF transcription factor TGF- transforming growth factor- TSC2 Tuberous Sclerosis Complex 2 VGCC voltage-gated L-type calcium channel YAP yes-associated protein YTHDF2 YTH domain family member 2 References 1
Marso, Steven P
Treatments counteracting oxidative stress, such as the antioxidant, N-acetylcysteine (NAC), have proven effective in preventing the emergence of behavioural and cognitive disruptions in various models of neurodevelopmental disorders [10, 41,42,43]
Linus Pauling Institute Oregon State University Reviewed in June 2021 by: Ralf R
These changes typically include lighter periods (reduced estrogen from fat loss), irregular cycle timing (metabolic stress response), shorter or longer cycles than baseline, and occasional skipped periods during active weight loss phase
Do GLP-1 medications really work for weight loss
